Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding

Area of Science:

• Nephrology
• Molecular Biology
• Genetics

Background:

• Familial hyperkalemic hypertension (FHHt) is linked to mutations in WNK4, KLHL3, and CUL3 genes.
• These mutations impair the cullin-RING-ligase (CRL) system, leading to WNK protein accumulation and upregulation of the NaCl cotransporter (NCC).
• The exact mechanism of CUL3-related FHHt remains unclear, with existing models being debated.

Purpose of the Study:

• To review recent research on the role of the COP9 signalosome (CSN) in CUL3 mutations causing FHHt.
• To explore the novel mechanism involving CSN dysregulation of CUL3 activity.
• To connect findings on CSN dysfunction to other related studies.

Main Methods:

• Review of recent in vitro and in vivo studies.
• Analysis of CSN interaction with mutant CUL3.
• Investigation of renal CSN impairment effects.
• Examination of CRL substrate adaptor degradation via auto-ubiquitination.

Main Results:

• Diminished CSN interaction with mutant CUL3 leads to CRL hyperneddylation.
• Direct renal CSN impairment replicates FHHt-like phenotypes, including lower KLHL3 and activated WNK-NCC pathway.
• CSN inhibition causes selective degradation of CRL substrate adaptors, resulting in substrate accumulation.

Conclusions:

• The COP9 signalosome plays a critical role in regulating CUL3 activity within the CRL system.
• Dysregulation of CSN is a key mechanism in CUL3-related familial hyperkalemic hypertension.
• Understanding CSN's role offers new insights into FHHt pathogenesis and potential therapeutic strategies.